With every new, approved drug comes payer expectations. To make sure that pharma meet the needs of this healthcare customer base it is critical that they demonstrate the value in their new products against the treatment standard. What follows is a listing of 7 new, exciting therapeutic agents which are facing challenges in the present US healthcare environment, and whose teams we predict will need to drive evidence development strategies to make their product a success.
Some drugs included in the ebook:
I hope you enjoy this ebook and please comment on our Total Biopharma community if you feel we left some great examples out.
For more on Evidence USA happening this 22-24 October in Boston, download the brochure